Journals / Türkiye Diyabet ve Obezite Dergisi / 2023 / Cilt: 7 Sayı: 2

Effect of Low Fat and Low Cholesterol Diet Intervention on LDL Subgroups in Dyslipidemic Patients: Epidemiological Observational Study

Dislipidemik Hastalarda Az Yağlı ve Az Kolesterollü Diyet Müdahalesinin LDL Alt Grupları Üzerine Etkisi: Epidemiyolojik Gözlemsel Çalışma

Pages
145–151
Publication Date
2023-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Release Date: May 15, 2021

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: According to studies, the individual cardiovascular disease (CVD) risk is predicted and low density lipoprotein cholesterol (LDL cholesterol) sub-group concentration better than LDL cholesterol.
📊
Key Findings & Data:The purpose of this study is to analogize LDL sub-group concentration pre and post a diet with LowFat and LowCholesterol written a prescription to dyslipidemic sicks along 3 months.
💡
Conclusion & Impact:Release Date: May 15, 2021
🔬Design:Research Article
📍Scope:2021 Verileri
⚙️Variables:Dislipidemi · LDL Alt Grupları · IDL Alt Grupları

Abstract

Aim: According to studies, the individual cardiovascular disease (CVD) risk is predicted and low density lipoprotein cholesterol (LDL cholesterol) sub-group concentration better than LDL cholesterol. High fat and cholesterol intakes are generally considered to pose a risk on CVD. The purpose of this study is to analogize LDL sub-group concentration pre and post a diet with LowFat and LowCholesterol written a prescription to dyslipidemic sicks along 3 months. Material and Methods: Diagnosticated dyslipidemia sicks (n=47) on the part of the endocrinologist were pursued along 3 months via a LowFat, LowCholesterol diet upon a lasting a month basis, on condition that they were proper for each. Before and after dietary intervention periods, biochemical parameters and anthropometric measurements were compared. Results: A sum of 47 participants (15 men and 32 women) with an average age of 48.51±9.86 years were involved. 13 women were at premenopausal and 19 women were at postmenopausal stages of 32 women involved. Small dense LDL (Sd-LDL) decreased from 11.0 (0.0-37.0) mg/dL at the beginning to 7.0 (0.0-68.1) mg/dL after the dietary intervention, but this decline was unimportant (p=0.686). Midbands (MiDC, MidB, MidA) subgroups of intermediate density lipoprotein cholesterol (IDL-cholesterol) declined considerably after dietary interference (p<0.001, p=0.008, p=0.045, respectively). Conclusion: A LowFat and LowCholesterol diet prescribed to dyslipidemic sicks (without using medicimes influencing lipid profile) along 3 months, had a positive impact on decreasing the sub-groups of IDL-cholesterol and LDL-cholesterol. Also, this dietary intervention induced beneficial impacts on anthropometric indications, tension and blood lipid profiles of the patients. Trial Registration: ClinicalTrials.gov ID: NCT04894318. Release Date: May 15, 2021

Özet

Amaç: Çalışmalara göre, düşük yoğunluklu lipoprotein kolesterol (LDL kolesterol) alt grup konsantrasyonları bireysel kardiyovasküler hastalık (KVH) riskini, LDL kolesterolden daha iyi tahmin etmektedir. Yağ ve kolesterolün fazla alımları genellikle kardiyovasküler hastalık (KVH) için bir risk olarak kabul edilir. Bu çalışmanın amacı, dislipidemik hastalara 3 ay süreyle az yağlı ve az kolesterollü bir diyetin öncesi ve sonrası LDL alt grup konsantrasyonunu karşılaştırmaktır. Gereç ve Yöntemler: Endokrinolog tarafından dislipidemi tanısı konulan hastalar (n=47) aylık olarak her birine özel olmak kaydıyla az yağlı, az kolesterollü diyetle 3 ay izlendi. Diyet müdahale dönemleri öncesi ve sonrası, biyokimyasal parametreler ve antropometrik ölçümler karşılaştırıldı. Bulgular: Yaş ortalaması 48,51±9,86 olan toplam 47 katılımcı (15 erkek ve 32 kadın) çalışmaya dahil edildi. Dahil edilen 32 kadından 13'ü menopoz öncesi, 19'u menopoz sonrası dönemdeydi. Çalışmanın başında 11,0 (0,0-37,0) mg/dL olan Small dense LDL (Sd-LDL), diyet müdahalesinden sonra 7,0 (0,0-68,1) mg/dL'ye düştü, ancak anlamlı değildi (p=0,686). Orta yoğunluklu lipoprotein kolesterolün (IDL-kolesterol) alt grupları MiDA, MidB, MidC diyet sonrası önemli ölçüde azaldı (sırasıyla, p=0,045, p=0,008, p<0,001). Sonuç: Dislipidemik hastalara (lipit profilini etkileyen ilaç kullanmayan) 3 ay boyunca verilen az yağlı ve az kolesterollü diyet, LDLkolesterol ve IDL-kolesterol alt gruplarını düşürmede olumlu etki göstermiştir. Ayrıca bu diyet, hastaların antropometrik ölçümleri, kan basıncı ve kan lipid profilleri üzerinde yararlı etkilere neden olmuştur.

🔖

Cite This Article

MUTLUTÜRK, Ü. K., ÇİÇEK, B., BAYRAM, F., DOĞRUEL, F. (2023). Effect of Low Fat and Low Cholesterol Diet Intervention on LDL Subgroups in Dyslipidemic Patients: Epidemiological Observational Study. Türkiye Diyabet ve Obezite Dergisi, Cilt: 7 Sayı: 2, 145–151. https://ajindex.com/articles/961033

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA. American Association of clinical endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012; 18(1): 1-78
  2. TEMD Obezite, Dislipidemi, Hipertansiyon Çalışma Grubu’ TEMD Dislipidemi Tanı ve Tedavi Kılavuzu’, Ankara, Nisan 2021; 14-16 (in Turkish)
  3. Bayram F, Kocer D, Gündoğan K, Kaya A, Demir Ö,Coşkun R, Sabuncu T, Karaman A, Cesur M, Rizzo M, Toth PP, Gedik V. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidology 2014; 8: 206-216
  4. Mahley RW, Palaogiu KE, Atak Z, Dawaon-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F, Ozbayrakq S, Giikdemir O, Winkler W. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res. 1995; 36: 839-859
  5. Bédard A, Corneau L, Lamarche B, Dodin S, Lemieux S. Sex differences in the impact of the Mediterranean diet on LDL particle size distribution and oxidation Nutrients. 2015;7(5): 3705-3723
  6. El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, Boekholdt SM. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007; 49: 547-553
  7. Ai M, Otokozawa S, Asztalos BF, Ito Y, Nakajima K, White CC, Cupples LA, Wilson PW, Schaefer EJ. Small dense LDL cholesterol and coronary heart disease: Results from the Framingham Offspring Study. Clin Chem. 2010; 56(6):967- 976
  8. Gerber PA, Nikolic D, Rizzo M. Small, dense LDL: an update. Curr Opin Cardiol. 2017;32(4):454-459
  9. Feingold, KR, Grunfeld, C. Introduction to lipids and lipoproteins. Endotext; MDText.com Inc, 2018
  10. Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxid Med Cell Longev. 2017;2017:1273042
  11. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1):111-188
  12. Schwingshack L, H